| 000 | 01836 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516030259.0 | ||
| 264 | 0 | _c20110627 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1098-5549 | ||
| 024 | 7 |
_a10.1128/MCB.05234-11 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohnstone, Duncan B | |
| 245 | 0 | 0 |
_aPodocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy. _h[electronic resource] |
| 260 |
_bMolecular and cellular biology _cMay 2011 |
||
| 300 |
_a2162-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aApolipoprotein L1 |
| 650 | 0 | 4 |
_aApolipoproteins _xgenetics |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 |
_aGlomerulosclerosis, Focal Segmental _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
| 650 | 0 | 4 |
_aLipoproteins, HDL _xgenetics |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aMyosin Heavy Chains _xgenetics |
| 650 | 0 | 4 |
_aNonmuscle Myosin Type IIA _xgenetics |
| 650 | 0 | 4 |
_aNonmuscle Myosin Type IIB _xgenetics |
| 650 | 0 | 4 | _aPodocytes |
| 650 | 0 | 4 |
_aProteinuria _xgenetics |
| 650 | 0 | 4 | _aSequence Deletion |
| 700 | 1 | _aZhang, Jidong | |
| 700 | 1 | _aGeorge, Britta | |
| 700 | 1 | _aLéon, Catherine | |
| 700 | 1 | _aGachet, Christian | |
| 700 | 1 | _aWong, Hetty | |
| 700 | 1 | _aParekh, Rulan | |
| 700 | 1 | _aHolzman, Lawrence B | |
| 773 | 0 |
_tMolecular and cellular biology _gvol. 31 _gno. 10 _gp. 2162-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/MCB.05234-11 _zAvailable from publisher's website |
| 999 |
_c20674065 _d20674065 |
||